For all their impressive capabilities, large language models (LLMs) often fall short when given challenging new tasks that require complex reasoning skills.

Data is in a very real sense the chief product of test centers within the Army Test and Evaluation Command (ATEC).U.S. Army ...

With version control, access management, and workflow automation built in, these platforms streamline reviews, approvals, and ...

Overcoming test data hurdles with realistic synthetic data Quality datasets are crucial for AI training, but the need to protect real-world data can slow development and implementation.

Blackstone is not alone. Data centers are drawing a crowd on Wall Street — investment giants like KKR, BlackRock and Blue Owl have collectively plowed hundreds of billions into the industry.

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing ...

Poster Presentation Title: Safety and Tolerability of 30-Minute Ublituximab Infusions: Updates from the ENHANCE Study Presentation Date/Time: Poster Session Thurs. May 29, 5:00 - 7:00 pm MST/8pm ET ...

Feedzai, a provider of fraud and financial crime prevention services, has acquired Demyst, a data management company. The deal includes Demyst’s Zonic data workflow orchestration platform ...

NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced the presentation of data yesterday highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing ...

If test data management isn't in place, it becomes very time-consuming for engineers to manually refresh and reset databases. This can tremendously slow down the CI/CD process, thereby leading to ...

FORT EISENHOWER, GA– Army Cyber Command (ARCYBER), the Army’s premier force for data-centric operations, is committed to implementing the Army’s Data Management and Analytics Strategy. In ...

NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy) data in patients ...